Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells

被引:21
|
作者
Long, Joseph [1 ,2 ]
Hoban, Megan D. [1 ]
Cooper, Aaron R. [3 ]
Kaufman, Michael L. [1 ]
Kuo, Caroline Y. [4 ]
Campo-Fernandez, Beatriz [1 ]
Lumaquin, Dianne [1 ]
Hollis, Roger P. [1 ]
Wang, Xiaoyan [5 ]
Kohn, Donald B. [1 ,6 ]
Romero, Zulema [1 ]
机构
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 3146 Terasaki Life Sci Bldg, Los Angeles, CA 90095 USA
[2] Calif State Univ Northridge, Biol Dept, Northridge, CA 91330 USA
[3] Univ Calif Los Angeles, Mol Biol Interdept PhD Program, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Allergy & Immunol, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Dept Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA
关键词
ZINC-FINGER NUCLEASES; SEVERE COMBINED IMMUNODEFICIENCY; STEM-CELLS; RETROVIRAL VECTOR; BCL11A KNOCKDOWN; COPY NUMBER; DISEASE; THERAPY; CRISPR-CAS9; THALASSEMIA;
D O I
10.1016/j.ymthe.2017.11.001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The use of engineered nucleases combined with a homologous DNA donor template can result in targeted gene correction of the sickle cell disease mutation in hematopoietic stem and progenitor cells. However, because of the high homology between the adjacent human beta- and delta-globin genes, off-target cleavage is observed at delta-globin when using some endonucleases targeted to the sickle mutation in beta-globin. Introduction of multiple double-stranded breaks by endonucleases has the potential to induce intergenic alterations. Using a novel droplet digital PCR assay and high-throughput sequencing, we characterized the frequency of rearrangements between the beta- and delta-globin paralogs when delivering these nucleases. Pooled CD34(+) cells and colony-forming units from sickle bone marrow were treated with nuclease only or including a donor template and then analyzed for potential gene rearrangements. It was observed that, in pooled CD34(+) cells and colony-forming units, the intergenic beta-delta-globin deletion was the most frequent rearrangement, followed by inversion of the intergenic fragment, with the inter-chromosomal translocation as the least frequent. No rearrangements were observed when endonuclease activity was restricted to on-target beta-globin cleavage. These findings demonstrate the need to develop site-specific endonucleases with high specificity to avoid unwanted gene alterations.
引用
收藏
页码:468 / 479
页数:12
相关论文
共 50 条
  • [21] Progress and Prospects of Gene Editing in Pluripotent Stem Cells
    Zhang, Zhenwu
    Bao, Xinyu
    Lin, Chao-Po
    BIOMEDICINES, 2023, 11 (08)
  • [22] Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
    Mettananda, Sachith
    Fisher, Chris A.
    Hay, Deborah
    Badat, Mohsin
    Quek, Lynn
    Clark, Kevin
    Hublitz, Philip
    Downes, Damien
    Kerry, Jon
    Gosden, Matthew
    Telenius, Jelena
    Sloane-Stanley, Jackie A.
    Faustino, Paula
    Coelho, Andreia
    Doondeea, Jessica
    Usukhbayar, Batchimeg
    Sopp, Paul
    Sharpe, Jacqueline A.
    Hughes, Jim R.
    Vyas, Paresh
    Gibbons, Richard J.
    Higgs, Douglas R.
    NATURE COMMUNICATIONS, 2017, 8
  • [23] Gene Editing of Stem Cells to Model and Treat Disease
    Hollywood J.A.
    Sanz D.J.
    Davidson A.J.
    Harrison P.T.
    Current Stem Cell Reports, 2018, 4 (3) : 253 - 263
  • [24] Enrichment of Human Hematopoietic Stem/Progenitor Cells Facilitates Transduction for Stem Cell Gene Therapy
    Baldwin, Kismet
    Urbinati, Fabrizia
    Romero, Zulema
    Campo-Fernandez, Beatriz
    Kaufman, Michael L.
    Cooper, Aaron R.
    Masiuk, Katelyn
    Hollis, Roger P.
    Kohn, Donald B.
    STEM CELLS, 2015, 33 (05) : 1532 - 1542
  • [25] The human ankyrin 1 promoter insulator sustains gene expression in a β-globin lentiviral vector in hematopoietic stem cells
    Romero, Zulema
    Campo-Fernandez, Beatriz
    Wherley, Jennifer
    Kaufman, Michael L.
    Urbinati, Fabrizia
    Cooper, Aaron R.
    Hoban, Megan D.
    Baldwin, Kismet M.
    Lumaquin, Dianne
    Wang, Xiaoyan
    Senadheera, Shantha
    Hollis, Roger P.
    Kohn, Donald B.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2015, 2 : 15012
  • [26] Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency
    Fananas-Baquero, Sara
    Quintana-Bustamante, Oscar
    Dever, Daniel P.
    Alberquilla, Omaira
    Sanchez-Dominguez, Rebeca
    Camarena, Joab
    Ojeda-Perez, Isabel
    Dessy-Rodriguez, Mercedes
    Turk, Rolf
    Schubert, Mollie S.
    Lattanzi, Annalisa
    Xu, Liwen
    Lopez-Lorenzo, Jose L.
    Bianchi, Paola
    Bueren, Juan A.
    Behlke, Mark A.
    Porteus, Matthew
    Segovia, Jose-Carlos
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 22 : 237 - 248
  • [27] Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing inBone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells
    Chang, Kai-Hsin
    Smith, Sarah E.
    Sullivan, Timothy
    Chen, Kai
    Zhou, Qianhe
    West, Jason A.
    Liu, Mei
    Liu, Yingchun
    Vieira, Benjamin F.
    Sun, Chao
    Hong, Vu P.
    Zhang, Mingxuan
    Yang, Xiao
    Reik, Andreas
    Urnov, Fyodor D.
    Rebar, Edward J.
    Holmes, Michael C.
    Danos, Olivier
    Jiang, Haiyan
    Tan, Siyuan
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2017, 4 : 137 - 148
  • [28] Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approaches
    Lamsfus-Calle, Andres
    Daniel-Moreno, Alberto
    Urena-Bailen, Guillermo
    Raju, Janani
    Antony, Justin S.
    Handgretinger, Rupert
    Mezger, Markus
    BLOOD REVIEWS, 2020, 40
  • [29] The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation
    Dever, Daniel P.
    Porteus, Matthew H.
    CURRENT OPINION IN HEMATOLOGY, 2017, 24 (06) : 481 - 488
  • [30] Reduction of BCL11A in hematopoietic stem cells through gene editing: new strategy to ameliorate the severe β-globin disorders sickle cell disease
    Hong, Weiqi
    Huang, Mengyuan
    Wei, Yuquan
    Wei, Xiawei
    SCIENCE BULLETIN, 2019, 64 (21) : 1562 - 1564